Literature DB >> 25757200

The combined effects of serum lipids, BMI, and fatty liver on 18F-FDG uptake in the liver in a large population from China: an 18F-FDG-PET/CT study.

Guobing Liu1, Yanli Li, Pengcheng Hu, Dengfeng Cheng, Hongcheng Shi.   

Abstract

OBJECTIVES: The aim of the study was to investigate the combined effects of serum lipids, BMI, and fatty liver on the liver uptake of fluorine-18 fluorodeoxyglucose ((18)F-FDG).
METHODS: A total of 676 individuals were retrospectively studied. The mean standardized uptake value (SUV) was used to quantify liver (18)F-FDG uptake. Univariate analyses and multivariate regression models identified variables that predicted the mean liver SUV before and after dichotomizing participants into low and high BMI groups.
RESULTS: The mean liver SUV (1.831 ± 0.417) differed significantly among nutritional categories (P = 0.005) and degrees of fatty liver (P < 0.001). An increase in mean liver SUV was noted in individuals with mild and moderate fatty liver compared with normal individuals and in overweight individuals compared with underweight individuals, whereas a downward trend was identified in both individuals with severe fatty liver and those who were obese. BMI had the strongest association with severity of fatty liver (r = 0.443, P < 0.001). Triglyceride, HDL, apolipoprotein-A, age, and BMI were independent variables predicting liver SUV mean in the whole population, whereas fatty liver severity presented as an independent variable only in the low BMI population (P = 0.031).
CONCLUSION: BMI, age, triglyceride, HDL, and apolipoprotein-A were independent variables predicting liver (18)F-FDG uptake. Mild and moderate degree of fatty liver had a positive effect on liver (18)F-FDG uptake, whereas a severe degree of fatty liver negatively affected (18)F-FDG uptake. Attention should be paid to liver metabolism in patients with fatty liver before using liver as the comparator in determining focal (18)F-FDG uptake elsewhere within the abdomen.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25757200     DOI: 10.1097/MNM.0000000000000301

Source DB:  PubMed          Journal:  Nucl Med Commun        ISSN: 0143-3636            Impact factor:   1.690


  5 in total

1.  Mean standardized uptake value (SUVmean) and global hepatic glycolysis as potential imaging markers reflecting hepatic functional capacity: evidence from 18F-FDG PET/CT.

Authors:  X Yue; J Wang; F Ye; D Xiao
Journal:  Hippokratia       Date:  2018 Oct-Dec       Impact factor: 0.471

2.  Effects of Fever on 18F-FDG Distribution In Vivo: a Preliminary Study.

Authors:  Yutang Yao; Junjun Cheng; Minggang Su; Xiaohong Ou
Journal:  Mol Imaging Biol       Date:  2020-08       Impact factor: 3.488

3.  Reproducibility of [18F]FDG PET/CT liver SUV as reference or normalisation factor.

Authors:  Gerben J C Zwezerijnen; Jakoba J Eertink; Maria C Ferrández; Sanne E Wiegers; Coreline N Burggraaff; Pieternella J Lugtenburg; Martijn W Heymans; Henrica C W de Vet; Josée M Zijlstra; Ronald Boellaard
Journal:  Eur J Nucl Med Mol Imaging       Date:  2022-09-27       Impact factor: 10.057

4.  Concurrent Low Brain and High Liver Uptake on FDG PET Are Associated with Cardiovascular Risk Factors.

Authors:  Hyun-Yeol Nam; Sungmin Jun; Kyoungjune Pak; In Joo Kim
Journal:  Korean J Radiol       Date:  2017-02-07       Impact factor: 3.500

5.  Improvement of liver metabolic activity in people with advanced HIV after antiretroviral therapy initiation.

Authors:  Reema Patel; Maura M Manion; Elizabeth Laidlaw; Paul Wakim; Zeping Wang; Megan Anderson; Frances Galindo; Adam Rupert; Andrea Lisco; Theo Heller; Irini Sereti; Dima A Hammoud
Journal:  AIDS       Date:  2022-08-03       Impact factor: 4.632

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.